Commentary

Drug Hypersensitivity Reactions Presenting as a Morbilliform Eruption With Islands of Sparing [letter]

Author and Disclosure Information

Cutaneous adverse drug reactions are common in hos­pitalized patients and contribute to patient morbidity, prolonged hospital stays, and the rising cost of health­care. In the hospitalized patient with a drug eruption and an extensive medication list, identifying the culpa­ble drug often is a challenging task. Physicians relying on clinical and histopathological clues must recognize a wide range of clinicopathologic entities that comprise cutaneous manifestations of drug reactions. Well-described patterns include morbilliform, urticarial, papulosquamous, lichenoid, bullous, erosive, pustular, eczematous, and fixed drug eruptions. Two cases of cephalosporin-induced drug eruptions manifesting as widespread morbilliform eruptions with islands of spar­ing and histologic evidence of spongiotic dermatitis on skin biopsy were diagnosed at the Columbia University Medical Center (CUMC), New York, New York.


 

Recommended Reading

Metal Orthopedic Implants Unlikely to Trigger Allergy
MDedge Dermatology
Tips for Spotting Dermatoses in Children With Darker Skin
MDedge Dermatology
Acrylates Named Contact Allergen of the Year
MDedge Dermatology
Antibiotics Are Top Contact Allergens Among Medications
MDedge Dermatology
Grover Disease (Transient Acantholytic Dermatosis) Induced by Anastrozole
MDedge Dermatology
Iatrogenic Autoimmune Progesterone Dermatitis Caused by 17α-hydroxyprogesterone Caproate for Preterm Labor Prevention
MDedge Dermatology
Painful Annular Pustular Drug Eruption Induced by Erlotinib in a Patient With Non–Small Cell Lung Cancer [letter]
MDedge Dermatology
Contact Allergy to Dimethacrylate
MDedge Dermatology
Cutaneous Curvularia Infection of the Forearm
MDedge Dermatology
Sweet Syndrome Associated With Hydralazine-Induced Lupus Erythematosus
MDedge Dermatology